Aged and Adolescent Mice Did Not Show the Same THC Adaptation Pattern

Age changed the observed adaptation pattern in a mouse THC study. Repeated exposure altered movement and hippocampal receptor signaling in adolescent animals without producing the same findings in aged animals.

Behavior and tissue assays were separate

Researchers measured open-field movement after THC and studied cannabinoid-stimulated G-protein activity in hippocampal membranes. They also examined repeated JZL184 treatment and levels of the endogenous cannabinoid 2-arachidonoylglycerol in another age group.

The THC comparison depended on age

Movement suppression was weaker in THC-pretreated than untreated adolescent mice. The corresponding difference was not observed in aged mice. Hippocampal basal and stimulated signaling also decreased after THC pretreatment in adolescents but was not affected in the aged group.

A null adaptation result is not proof of no acute effect

Lack of a pretreatment-related difference does not mean aged animals were unaffected by THC. It concerns whether repeated exposure changed the measured response. Similarly, a hippocampal membrane assay does not describe every brain region or cognitive function.

The JZL184 findings depended on dose and measurement, illustrating another limit on generalizing across interventions that affect the same broad system. These results do not establish cannabis safety for older adults, explain an individual person's tolerance or provide a driving rule. Age, drug, tissue and endpoint must accompany any conclusion about receptor adaptation.

Related: interpreting cannabis tolerance claims.

Research cited

Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184. Naunyn-Schmiedeberg's archives of pharmacology (2016). doi:10.1007/s00210-016-1226-6. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

A 2026 narrative review argues that product potency is not the same as delivered THC dose and that placebo responses remain important among experienced users. Its laboratory framework also distinguishes reduced drug reinforcement from nonspecific sedation. Users can change how they inhale The review notes that participants alter inhalation patterns…

Spread the love

Read Article: A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A 1999 rat study found that tolerance weakened THC-related modulation of spinal dynorphin, while antinociception could still occur without the same elevated dynorphin measure. The role of a downstream signal changed with dose and adaptive state. The experiment examined spinal responses The work followed earlier findings linking acute intrathecal THC…

Spread the love

Read Article: THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

A 2002 mouse experiment reported fewer antagonist-precipitated withdrawal signs with a Passiflora-derived benzoflavone fraction. The finding concerns a defined experimental preparation and animal model, not a demonstrated treatment for cannabis-use disorder in people. Concurrent and acute interventions were tested Mice received repeated oral THC with or without the fraction. A…

Spread the love

Read Article: A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us